B+
Bull case
25%
Probability
Target price
$12.00
Analysis reference price unavailable
Analysis 2025-10-26 · RankAlpha Sentiment AI
DYN
Dyne TherapeuticsFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
Positive pivotal/registrational readouts and a strategic partner would validate Dyne’s delivery platform, supporting a recovery toward prior highs and a re‑rating to the bull target.
Posture
Defensive
Lead driver
Value
What changed
1 setup hits (3d) with net bullish as of 2026-09-08.
What can break
Clinical trial failure or negative readouts
Momentum
54
Value
41
Sentiment
0
Setup hits (3d)
1 · Net Bullish
AI TargetsBase $8.00 · Bull $12.00 · Bear $5.00Analysis 2025-10-26; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-08 • Model: HYBRID_IC_RP
AI Memo
As of 2025-10-26 • Model: RankAlpha Sentiment AI
Investment thesisAs of 2026-09-08
Investment thesis
As of 2026-09-08
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-08. Definitions
Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net Bullish
Target $39.50
Why
Momentum54 · Δ7d -19.6
Value41 · Δ7d -0.0
Sentiment0 · Δ7d 0.0
So what
Weak posture (Net Bullish). Prioritize risk control and patience.
Confirming evidence
- • 1 setup hits (3d) with net bullish as of 2026-09-08.
- • Value remains the lead driver in the composite, 7D delta -0.0.
Contradictions & invalidation
- • Clinical trial failure or negative readouts
- • Delivery/safety issues with the platform
- • Clinical setbacks, persistent safety/delivery issues, or dilutive financings could compress valuation toward cash/runway-adjusted levels, consistent with the bear target.
Catalyst clock
No dated catalyst is available.
Pivotal or registrational trial readouts for DMD/other programs
Lead driver: Value · See fundamentals
Momentum
54
9% active weight
Current posture
7d trendSoftening
Δ7d
-19.6
Δ21d
-44.2
Value
41
28% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.1
Sentiment
0
62% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
0.0
Why this grade
Composite grade F. Momentum 53.8 / Value 41.2 / Sentiment 0.0
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2025-10-26. Scenario method
Most likely
B
Base case
50%
Probability
Target price
$8.00
Analysis reference price unavailable
Analysis 2025-10-26 · RankAlpha Sentiment AI
B-
Bear case
25%
Probability
Target price
$5.00
Analysis reference price unavailable
Analysis 2025-10-26 · RankAlpha Sentiment AI
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$4.88B
Beta
1.31
Shares Out
186.75M
P/E (TTM) · Derived
-7.5
P/S (TTM)
-
P/FCF (TTM) · Derived
-8.14
Rev YoY
-
EPS YoY
+10.9%
Gross Margin
-
Op Margin
-
Net Debt
-$941.36M
Current Ratio
12.02
As of 2026-09-08 • Updated nightlySource: Internal modelMethods & Data